Bacterial Production of Custom Sequence and Length ssDNA

Exclusively Licensed

Methods and compositions for bacterial production of pure single-stranded DNA (ssDNA) composed of custom sequence and size have been developed. The methods enable scalability and bio-orthogonality in applications of scaffolded DNA origami, offering one-step purification of large quantities of pure ssDNA amendable for immediate folding of DNA nanoparticles. The methods produce pure ssDNA directly from bacteria. In some embodiments the E. coli helper strain M13cp combined with a phagemid carrying only an f1-origin allows for, without the need for additional purification from contaminating dsDNA. This system is useful for generalized circular ssDNA synthesis, and here is applied to the assembly of DNA nanoparticles folded both in vitro and direct from phage.

Researchers

Mark Bathe / Rebecca Du / Tyson Shepherd

Departments: Department of Biological Engineering
Technology Areas: Biotechnology: Biomanufacturing, DNA & RNA Editing, Synthetic Biology / Drug Discovery and Research Tools: Genomics & Proteomics
Impact Areas: Healthy Living

  • microbial production of pure single stranded nucleic acids
    European Patent Convention | Published application
  • microbial production of pure single stranded nucleic acids
    United States of America | Granted | 10,940,171

License this technology

Interested in this technology? Connect with our experienced licensing team to initiate the process.

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.